1.0
Dec 22, 2016
Anonymous employee
Former employee
Recommend
CEO approval
Business outlook
Pros
BioTime successfully transitioned from blood products to stem cell focus at an excellent time, and attracted some strong backers with excellent resources and know-how.
Cons
Internal management is scattered and unfocused. CEO Mike West consistently opts for expenditures based on personal whims and self-glorification rather than overall company well-being. Rewards are rarely based on merit.